The Effect of Atorvastatin on Oxidative Stress and Renal Function in Experimental Model of Diabetic Nephropathy

The Effect of Atorvastatin on Oxidative Stress and Renal Function in Experimental Model of Diabetic Nephropathy

Background and Objectives: Atorvastatin has multiple effects independent of lipid lowering, such as anti-inflammatory and antioxidant. The present study was performed with the purpose of determining the effect of atorvastatin on renal function and oxidative stress response in experimental model of d...

Full description

Bibliographic Details
Main Authors:	Nastaran Faghihi, Mohammad Taghi Mohammadi, Akram Eidi
Format:	Article
Language:	fas
Published:	Qom University of Medical Sciences 2016-01-01
Series:	Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum
Subjects:	diabetic nephropathy atorvastatin hyperglycemia oxidative stress.
Online Access:	http://journal.muq.ac.ir/browse.php?a_code=A-10-24-7&slc_lang=en&sid=1

Similar Items

Anti-Inflammatory Effects of Atorvastatin by the Modulation of NF-κB Expression during Hyperglycemia-Induced Nephropathy in Rat
by: Mohammad Taghi Mohammadi, et al.
Published: (2016-03-01)

Effect of atorvastatin on hyperglycemia-induced brain oxidative stress and neuropathy induced by diabetes
by: Nastaran Faghihi, et al.
Published: (2015-04-01)

Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: An in vitro study
by: Haleema Shahin DH, et al.
Published: (2024-05-01)

Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
by: Haitham Galal, et al.
Published: (2015-12-01)

Effect of combined Atorvastatin and zinc oxide on the biochemical and histopathological alterations in kidney of diabetic rats
by: Zahra Karampour Gebchag, et al.
Published: (2019-06-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Juglans Regia L. Leaf Extract Attenuates Diabetic Nephropathy Progression in Experimental Diabetes: An Immunohistochemical Study
by: Davood Nasiry, et al.
Published: (2019-01-01)

The Mechanism of Hyperglycemia-Induced Renal Cell Injury in Diabetic Nephropathy Disease: An Update
by: Tong Wu, et al.
Published: (2023-02-01)

Anti-Oxidative Therapy in Diabetic Nephropathy
by: Luis F. Hernandez, et al.
Published: (2022-05-01)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
by: Samad Golshani, et al.
Published: (2022-01-01)

The Effect of Atorvastatin on Inflammatory Markers in Patients with Type Two Diabetes
by: Afsaneh Talaei, et al.
Published: (2018-08-01)

Up-Date on Diabetic Nephropathy
by: Maria Chiara Pelle, et al.
Published: (2022-08-01)

Evaluating the Proposed Mechanism by Which Atorvastatin Can Protect Renal Tissue against Contrast Media: An Animal study
by: Samer Jaffar Sharif, et al.
Published: (2019-03-01)

FREQUENCY AND CORRELATES OF MYOPATHY IN PATIENTS WITH DIABETES TAKING ATORVASTATIN
by: Kamil Rehman Butt, et al.
Published: (2021-04-01)

The Effect of Atorvastatin on Inslin Resistance in Patients with Type Two Diabetes
by: Afsaneh Talaei, et al.
Published: (2019-06-01)

Antidiabetic and Nephroprotective Effects of Polysaccharide Extract from the Seaweed Caulerpa racemosa in High Fructose-Streptozotocin Induced Diabetic Nephropathy
by: Cao M, et al.
Published: (2021-05-01)

The Effects of Combined Atorvastatin and Zinc Oxide on Some Markers of Oxidative Stress in the Hippocampus in Streptozotocin-induced Diabetic Rats
by: Z Karampour Qipchaq, et al.
Published: (2016-11-01)

Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
by: Weikun Jia, et al.
Published: (2021-02-01)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
by: Eugene Han, et al.
Published: (2017-06-01)

COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
by: Safina Shabbir, et al.
Published: (2020-12-01)

Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy
by: Sheila Bermejo, et al.
Published: (2016-09-01)

Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression
by: Xuyu He, et al.
Published: (2016-05-01)

Effect of Atorvastatin in Lipid Profile Changes and Inflammation Marker TNF-alpha on Diabetes Patient with Dyslipidemia
by: Wulan Panduwi Melasari, et al.
Published: (2021-04-01)

Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model
by: El-Ebidi AM, et al.
Published: (2020-10-01)

Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications
by: Petya Goycheva, et al.
Published: (2023-08-01)

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
by: Maryam Paseban, et al.
Published: (2019-03-01)

Protective effects of atorvastatin on myocardium in hypertensive rats
by: Mohammad Taghi Mohammadi, et al.
Published: (2013-02-01)

Does curcumin or metformin attenuate oxidative stress and diabetic nephropathy in rats?
by: Soheila Asadi, et al.
Published: (2019-01-01)

Atorvastatin and carnitine combination versus atorvastatin alone impacts on the lipid profile of haemodialyzed patients: A randomised clinical trial
by: Hamid Noshad, et al.
Published: (2018-12-01)

Antidiabetic and Antinephropathic Potential of Ajwa Pit & Pulp (Phoenix dactylifera) in Alloxanized Diabetic Rats
by: Iram Imran, et al.
Published: (2020-12-01)

The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats
by: Sheila Marques Fernandes, et al.
Published: (2016-08-01)

The effect of the various doses of atorvastatin on renal tubular cells; an experimental study
by: Hamid Nasri, et al.
Published: (2016-07-01)

Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model
by: Maedeh Hamzeh, et al.
Published: (2018-01-01)

An Overview of Diabetic Nephropathy
by: Alp Atasoy, et al.
Published: (2015-03-01)

Irbesartan attenuates renal injury with diabetic nephropathy rats
by: ZHANG Ya, HUANG Wen-hui, HOU Zhi-min, LIU Ju-xiang, LIU Jing
Published: (2020-04-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01)

Can atorvastatin calcium cause asymptomatic hypercalcemia?
by: Suleyman Hilmi Ipekci, et al.
Published: (2014-10-01)

Evaluation of periodontal health in patients taking atorvastatin
by: Kosar Rezaei Talarposhti, et al.
Published: (2018-09-01)

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
by: Qi Jin, et al.
Published: (2023-07-01)